Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02994602 · ClinicalTrials.gov registry record · Phase 1
Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males
A Phase 1 study of Healthy Women and Male Contraception, sponsored by Kimberly Myer.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
- 2
- Study locations
NCT02994602 is a Phase 1 study of Healthy Women and Male Contraception that has completed, run by Kimberly Myer. The registered enrollment target is 26 participants, below the 58-participant average among 4 other Healthy Women trials with a reported enrollment target (55% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02994602, a Phase 1 study of Healthy Women and Male Contraception, has completed, sponsored by Kimberly Myer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a two-center, open-label study conducted in healthy male and female volunteers at two academic research centers. The study will consist of three single applications of the Nestorone (NES) + testosterone (T) combined gel on the shoulders/upper arms of male participants followed 2 hours later by supervised skin contact by the non-dosed female participants on the application site on days 1, 8, and 15. Effect of Washing or Clothing Barrier to the Application will be assessed.
Conditions Studied
Interventions
- DRUG Nestorone + Testosterone Combination Gel
Study Locations (2)
California
- Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Torrance
Washington
- University of Washington Medical Center & Health Sciences - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02994602
The ClinicalTrials.gov registry entry for NCT02994602 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 4 other Healthy Women trials with a reported enrollment target (55% lower). The listed sponsor is Kimberly Myer, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Healthy Women appearing as the primary indexed condition, and to 1 intervention - of which Nestorone + Testosterone Combination Gel is the first listed.
NCT02994602 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Washington.
Frequently Asked Questions
What is clinical trial NCT02994602 about?
NCT02994602 is a clinical study titled "Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males". This is a two-center, open-label study conducted in healthy male and female volunteers at two academic research centers. The study will consist of three single applications of the Nestorone (NES) + testosterone (T) combined gel on the shoulders/upper arms of male participants followed 2 hours later ...
What is the current status of trial NCT02994602?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2017-01. Estimated completion is 2017-10.
What conditions does trial NCT02994602 study?
This clinical trial studies the following conditions: Healthy Women, Male Contraception, Healthy Men, Product Transference.
What interventions are being tested in trial NCT02994602?
The interventions under investigation include: Nestorone + Testosterone Combination Gel (DRUG).
Who is sponsoring clinical trial NCT02994602?
This trial is sponsored by Kimberly Myer, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02994602 being conducted?
This trial has 2 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Women
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
ACTIVE NOT RECRUITING · Phase 1
-
The Effect of the Menstrual Cycle on Immune Cell Activity and Recovery After Resistance Exercise
RECRUITING
-
TMS-Induced LH Response in Healthy Women in Luteal Phase
RECRUITING · NA
-
Exercise Intensity, Metabolic Rate and Insulin Sensitivity
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.